The groundbreaking success of Sildenafil undeniably transformed the pharmaceutical landscape, but betting in companies heavily reliant on unbranded versions presents a uncertain picture. While early returns were significant, the expiration of patents and the appearance of less expensive alternatives have eroded the customer base. Therefore, a thoro